{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:01:56Z","timestamp":1787763716544,"version":"build-2784847793"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186341","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T13:57:18Z","timestamp":1507816638000},"page":"e0186341","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3109-0662","authenticated-orcid":true,"given":"Sebastian","family":"Zschaeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiana","family":"Bl\u00fcmke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Bahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Sinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Pelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Budach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirus","family":"Ghadjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"JP Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","article-title":"Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial","volume":"297","author":"H Oettle","year":"2007","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.clon.2014.06.002","article-title":"Locally advanced pancreatic cancer: the role of definitive chemoradiotherapy","volume":"26","author":"F Huguet","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002689900215","article-title":"Recurrence after resection for ductal adenocarcinoma of the pancreas","volume":"21","author":"C Sperti","year":"1997","journal-title":"World J Surg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4251\/wjgo.v7.i12.375","article-title":"Multimodality treatment of recurrent pancreatic cancer: Mith or reality?","volume":"7","author":"C Sperti","year":"2015","journal-title":"World J Gastrointest Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s11605-012-1912-8","article-title":"Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection","volume":"16","author":"RM Thomas","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1200\/JCO.1985.3.3.373","article-title":"Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil\u2014an Eastern Cooperative Oncology Group study","volume":"3","author":"DJ Klaassen","year":"1985","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Tria","volume":"315","author":"P Hammel","year":"2016","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/annonc\/mdn281","article-title":"Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000\u201301 FFCD\/SFRO study","volume":"19","author":"B Chauffert","year":"2008","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.2006.07.5663","article-title":"Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies","volume":"25","author":"F Huguet","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cncr.22735","article-title":"Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy","volume":"110","author":"S Krishnan","year":"2007","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","article-title":"Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial","volume":"29","author":"PJ Loehrer","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1002\/cncr.29652","article-title":"Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base","volume":"121","author":"CE Rutter","year":"2015","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijrobp.2015.12.003","article-title":"Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation","volume":"94","author":"S Krishnan","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"452089","DOI":"10.1155\/2014\/452089","article-title":"Intensity-modulated and image-guided radiotherapy in patients with locally advanced inoperable pancreatic cancer after preradiation chemotherapy","volume":"2014","author":"M Sinn","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1748-717X-5-28","article-title":"Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence","volume":"5","author":"W Sun","year":"2010","journal-title":"Radiat Oncol"},{"key":"ref17","article-title":"Dose escalation in locally advanced pancreatic cancer patients receiving chemoradiotherapy","author":"SY Chung","year":"2017","journal-title":"Radiotherapy and Oncology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.ijrobp.2012.02.051","article-title":"A phase I\/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer","volume":"84","author":"E Ben-Josef","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"45845","DOI":"10.1038\/srep45845","article-title":"Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer","volume":"7","author":"M Fiore","year":"2017","journal-title":"Sci Rep"},{"key":"ref20","article-title":"Inter- and intrafractional variation in the three-dimensional positions of pancreatic tumors due to respiration under real-time monitoring","author":"M Akimoto","year":"2017","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.radonc.2016.09.012","article-title":"Abdominal organ motion during inhalation and exhalation breath-holds: pancreatic motion at different lung volumes compared","volume":"121","author":"E Lens","year":"2016","journal-title":"Radiother Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2016.07.012","article-title":"Comparative evaluation of respiratory-gated and ungated FDG-PET for target volume definition in radiotherapy treatment planning for pancreatic cancer","volume":"120","author":"T Kishi","year":"2016","journal-title":"Radiother Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.ijrobp.2012.09.035","article-title":"Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer","volume":"85","author":"P Kelly","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.radonc.2016.12.030","article-title":"Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: Secondary analysis of a prospective clinical trial","volume":"122","author":"V Verma","year":"2017","journal-title":"Radiother Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","article-title":"Radiation dose-volume effects in the stomach and small bowel","volume":"76","author":"BD Kavanagh","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref26","first-page":"CD006053","article-title":"Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma","volume":"2","author":"FJ H\u00fcttner","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.3747\/co.23.2771","article-title":"Dosimetric and clinical toxicity comparison of critical organ preservation with three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and RapidArc for the treatment of locally advanced cancer of the pancreatic head","volume":"23","author":"L Jin","year":"2016","journal-title":"Curr Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5009\/gnl15186","article-title":"A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer","volume":"10","author":"KJ Lee","year":"2016","journal-title":"Gut Liver"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13014-015-0566-6","article-title":"Is the irradiated small bowel volume still a predictor for acute lower gastrointestinal toxicity during preoperative concurrent chemo-radiotherapy for rectal cancer when using intensity-modulated radiation therapy?","volume":"10","author":"B Xu","year":"2015","journal-title":"Radiat Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.radonc.2015.07.036","article-title":"Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancer","volume":"116","author":"AK Trip","year":"2015","journal-title":"Radiother Oncol"},{"key":"ref31","article-title":"Does unintentional splenic radiation predict severe lymphopenia following pancreatic cancer radiotherapy?","author":"AS Chadha","year":"2016","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijrobp.2012.11.020","article-title":"Prognostic significance of carbohydrate antigen 19\u20139 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1\/2 dose escalation study","volume":"86","author":"JM Vainshtein","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0360-3016(03)00524-8","article-title":"Predictive value of carbohydrate antigen 19\u20139 in pancreatic cancer treated with radiochemotherapy","volume":"57","author":"O Micke","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e78977","DOI":"10.1371\/journal.pone.0078977","article-title":"Clinical Significance and Revisiting the Meaning of CA 19\u20139 Blood Level Before and After the Treatment of Pancreatic Ductal Adenocarcinoma: Analysis of 1,446 Patients from the Pancreatic Cancer Cohort in a Single Institution","volume":"8","author":"JK Park","year":"2013","journal-title":"PLoS ONE"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.ijrobp.2008.06.1483","article-title":"CA 19\u20139 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy","volume":"73","author":"WS Koom","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","article-title":"Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)","volume":"388","author":"K Uesaka","year":"2016","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e0156910","DOI":"10.1371\/journal.pone.0156910","article-title":"Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer","volume":"11","author":"AS Chadha","year":"2016","journal-title":"PLOS ONE"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00066-011-2226-6","article-title":"Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial","volume":"187","author":"S Maluta","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1016\/j.prro.2015.04.004","article-title":"Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation","volume":"5","author":"LS Wang","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/MPA.0000000000000365","article-title":"Cytoreductive Surgery for Pancreatic Cancer Improves Overall Outcome of Gemcitabine-Based Chemotherapy","volume":"44","author":"M Bahra","year":"2015","journal-title":"Pancreas"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T11:31:10Z","timestamp":1570188670000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186341"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186341","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]}}}